search
Back to results

Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV (HIVSSSA)

Primary Purpose

HIV Infections, ART, HIV Seropositivity

Status
Completed
Phase
Not Applicable
Locations
South Africa
Study Type
Interventional
Intervention
HIV self test
Counseling and referral for partner testing
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for HIV Infections focused on measuring HIV self testing, HIV self screening, South Africa

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. Adult female 18+ years old
  2. confirmed HIV-positive or on ART
  3. confirmed to currently have a male partner and are sexually active
  4. male partner is of HIV- or unknown status
  5. confirmed to have a cell phone that can read and respond to SMS/WhatsApp messages
  6. confirmed to be able to consent to study participation (no language constraints or psychological issues that would make it difficult to consent to participate in the study)

Exclusion Criteria:

Failure to meet all of inclusion criteria

Sites / Locations

  • Department of Health Clinics

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

HIV self testing

Standard of care

Arm Description

HIV+ women will receive HIV self-tests (2) to bring home to her partner to offer for testing

In the standard of care arm, women will receive standard of care partner referrals for HIV testing, including counselling about disclosure and referral for her partner(s) to return to the facility for testing.

Outcomes

Primary Outcome Measures

Partner HIV testing
proportion of index partners who report testing

Secondary Outcome Measures

Positivity
Proportion of male partners tested who test HIV+
ART initiation
Proportion of male partners tested who initiate ART
Viral suppression
Proportion of male partners and index partners who achieve viral suppression

Full Information

First Posted
September 29, 2021
Last Updated
October 11, 2021
Sponsor
University of California, Los Angeles
Collaborators
Emory University, BroadReach Healthcare, USAID, South Africa, South African Department of Health, Mpumalanga Province
search

1. Study Identification

Unique Protocol Identification Number
NCT05074251
Brief Title
Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV
Acronym
HIVSSSA
Official Title
Pilot Study of Secondary Distribution of HIV Self-screening Tests by Women With HIV: An Innovative Strategy to Improve Testing, Identification, and Linkage to Treatment of Men in South Africa
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
April 20, 2021 (Actual)
Primary Completion Date
August 6, 2021 (Actual)
Study Completion Date
August 24, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
Collaborators
Emory University, BroadReach Healthcare, USAID, South Africa, South African Department of Health, Mpumalanga Province

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Many South African men do not visit clinics or get tested due to multiple real and perceived barriers. Nkangala District has significant gaps to identifying PLHIV who are not on ART, reaching their ART targets, especially in adult men. Over 65% of PLHIV not on ART are men, which is a gap of over 39,000 men living with HIV needing to be tested and initiated on ART. To improve case finding among men in Nkangala we will evaluate how best to reach partners of PLHIV (newly diagnosed or on ART) with index testing by using HIV self-screening (HIVSS) and linkage to ART start. Secondary distribution of HIV self-screening kits (HIVSS), whereby clients bring HIVSS kits to their partners, addresses barriers by enabling partners to screen themselves at their convenience and in the privacy of their homes. Study Objectives: BroadReach in collaboration with UCLA, UCT and Nkangala DOH will pilot test an innovative index partner HIVSS strategy in one urban and one rural clinic to evaluate acceptability, barriers, and efficacy of secondary HIVSS distribution in a randomized control trial enrolling women newly diagnosed with HIV or on ART. In the intervention arm, women will receive counselling on how to use HIVSS, how to encourage their male partner to screen, and 2 oraquick HIVSS with instructions and invitation to return for confirmatory testing. In the standard of care arm, index women will receive counselling on the importance of disclosure to their family and partner(s) and referral for HIV testing (per South African national guidelines). Study design: Randomized control trial of n=180 WLHIV (90 in each arm) in four facilities (urban and rural) in the Nkangala district ensure that the results are generalizable.
Detailed Description
Many South African men do not visit clinics or get tested due to multiple real and perceived barriers. Nkangala District has significant gaps to identifying PLHIV who are not on ART, reaching their ART targets, especially in adult men. Over 65% of PLHIV not on ART are men, which is a gap of over 39,000 men living with HIV needing to be tested and initiated on ART. To improve case finding among men in Nkangala we will evaluate how best to reach partners of PLHIV (newly diagnosed or on ART) with index testing by using HIV self-screening (HIVSS) and linkage to ART start. Secondary distribution of HIV self-screening kits (HIVSS), whereby clients bring HIVSS kits to their partners, addresses barriers by enabling partners to screen themselves at their convenience and in the privacy of their homes. We will partner with BroadReach Healthcare, a PEPFAR partner in South Africa, to pilot test an innovative index partner HIVSS strategy in one urban and one rural public health clinic in the Nkangala district of Mpumalanga Province to evaluate acceptability, barriers, and preliminary efficacy of secondary HIVSS distribution in a randomized control trial enrolling women newly diagnosed with HIV or on ART. In the intervention arm, women will receive counselling on how to use HIVSS, how to encourage their male partner to screen, and 2 HIVSSs with HIVSS instructions and invitation to return for confirmatory testing. In the standard of care arm, index women will receive counselling on the importance of disclosure to their family and partner(s) and referral for HIV testing (per SA national guidelines). We will evaluate the following aims: Conduct a mixed-methods survey with N=180 HIV+ women to assess perceived acceptability and barriers (including perceived safety, IPV) to secondary HIVSS distribution by women to male partners. Test the feasibility and preliminary efficacy of secondary HIVSS distribution through a 1:1 randomized control trial in n=180 HIV+ women to assess, comparing standard of care to intervention arm: % of index women who self-report that they gave the HIVSS or standard of care referral for testing to their male partner % of male partners who either screened or tested for HIV assessed at 3 months after randomization (primary outcome) i. Measured via options of: index or partner self-report, SMS/WhatsApp of a picture of the used HIVSS sent by partner or index, return of a used self-test to the facility by either the index or partner, and/or partner coming into facility for with an invitation for confirmatory testing or SOC counseling referral c. % of male partners with a positive HIV screening/test result d. % of newly diagnosed male partners who initiate ART within 3 months of diagnosis e. % of those on ART with viral suppression after 6 months on ART (index and partners) In the intervention arm, we will assess acceptability and barriers (including safety/IPV) related to HIVSS distribution or use via surveys with all intervention participants who return for the study endline survey and a convenience samples of n=20 male partners (n=10 men who used HIVSS and n=10 men who did not use HIVSS)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections, ART, HIV Seropositivity
Keywords
HIV self testing, HIV self screening, South Africa

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
180 (Actual)

8. Arms, Groups, and Interventions

Arm Title
HIV self testing
Arm Type
Experimental
Arm Description
HIV+ women will receive HIV self-tests (2) to bring home to her partner to offer for testing
Arm Title
Standard of care
Arm Type
Active Comparator
Arm Description
In the standard of care arm, women will receive standard of care partner referrals for HIV testing, including counselling about disclosure and referral for her partner(s) to return to the facility for testing.
Intervention Type
Diagnostic Test
Intervention Name(s)
HIV self test
Other Intervention Name(s)
counseling on partner testing and HIV self testing
Intervention Description
For women allocated to the intervention arm, the participant will be given HIV self testing and counseling on their use & importance of partner testing, to take home to their partner(s).
Intervention Type
Behavioral
Intervention Name(s)
Counseling and referral for partner testing
Intervention Description
Counseling and refer participant's partner for facility based HIV testing
Primary Outcome Measure Information:
Title
Partner HIV testing
Description
proportion of index partners who report testing
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Positivity
Description
Proportion of male partners tested who test HIV+
Time Frame
3 months
Title
ART initiation
Description
Proportion of male partners tested who initiate ART
Time Frame
6 months
Title
Viral suppression
Description
Proportion of male partners and index partners who achieve viral suppression
Time Frame
6 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adult female 18+ years old confirmed HIV-positive or on ART confirmed to currently have a male partner and are sexually active male partner is of HIV- or unknown status confirmed to have a cell phone that can read and respond to SMS/WhatsApp messages confirmed to be able to consent to study participation (no language constraints or psychological issues that would make it difficult to consent to participate in the study) Exclusion Criteria: Failure to meet all of inclusion criteria
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristin Wall, PhD
Organizational Affiliation
Emory University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kathryn Dovel, PhD
Organizational Affiliation
University of California, Los Angeles
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Dhirisha Naidoo
Organizational Affiliation
BroadReach Healthcare
Official's Role
Study Director
Facility Information:
Facility Name
Department of Health Clinics
City
Nkangala
State/Province
Mpumalanga
Country
South Africa

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Will be made available upon request to study team
Citations:
PubMed Identifier
35690880
Citation
Joseph Davey DL, Wall KM, Naidoo N, Naidoo D, Xaba G, Serao C, Malone T, Dovel K. HIV testing and linkage to ART following secondary distribution of HIV self-test kits to male partners of women living with HIV: a pilot randomized control trial in Mpumalanga, South Africa. J Int AIDS Soc. 2022 Jun;25(6):e25937. doi: 10.1002/jia2.25937.
Results Reference
derived

Learn more about this trial

Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV

We'll reach out to this number within 24 hrs